Stockscreener 앱 받기
14.85
2.45%
0.355
시장 영업 전:
14.99
0.145
+0.98%
전일 마감가:
$14.49
열려 있는:
$14.38
하루 거래량:
621.58K
Relative Volume:
2.57
시가총액:
$533.72M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+33.14%
1개월 성능:
-27.48%
6개월 성능:
-43.98%
1년 성능:
+0.00%
1일 변동 폭
$14.30
$15.18
1주일 범위
$12.61
$15.87
52주 변동 폭
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
명칭
Ceribell Inc
전화
(800) 436-0826
주소
360 N. PASTORIA AVENUE, SUNNYVALE
CBLL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
14.85 | 533.72M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-04 | 개시 | Ladenburg Thalmann | Buy |
| 2024-11-05 | 개시 | BofA Securities | Buy |
| 2024-11-05 | 개시 | Canaccord Genuity | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Ceribell Inc 주식(CBLL)의 최신 뉴스
Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating - TipRanks
Vanguard Group Inc. Takes $18.02 Million Position in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4 - MSN
CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm - MSN
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - markets.businessinsider.com
Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithm - TipRanks
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm - marketscreener.com
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric - GlobeNewswire
Groundbreaking FDA Approval: Ceribell's AI Now Detects Seizures in Children Within Minutes - Stock Titan
Corebridge Financial Inc. Buys Shares of 6,122 CeriBell (NASDAQ:CBLL) - Defense World
Norges Bank Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
CeriBell (NASDAQ:CBLL) Shares Gap Up – Still a Buy? - Defense World
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Ceribell braces for tariff impact on margins By Investing.com - Investing.com Canada
CeriBell's Stock Climbs As Tariff Relief Extends To 2025 - Finimize
Sector Update: Health Care - TradingView
CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4 - MarketScreener
William Blair maintains Ceribell Outperform amid tariff concerns By Investing.com - Investing.com Canada
Canaccord maintains Ceribell stock buy rating, $33 target By Investing.com - Investing.com South Africa
William Blair maintains Ceribell Outperform amid tariff concerns - Investing.com Australia
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Canaccord maintains Ceribell stock buy rating, $33 target - Investing.com
Ceribell, Inc.: Strategic Resilience and Financial Health Amid Market Challenges - TipRanks
Ceribell braces for tariff impact on margins - Investing.com Australia
Data-Based Insights About Ceribell Inc (CBLL) - stocksregister.com
Ceribell, Inc. Addresses Impact of New U.S. Tariffs - TipRanks
CeriBell addresses impact of new U.S. tariffs on Chinese imports - grafa.com
institutional investors of CeriBell, Inc. (NASDAQ:CBLL) must be disappointed after last week's 40% drop - simplywall.st
Ceribell, Inc.: Strategic Maneuvers Boost Gross Margin Amid Tariff Challenges, Supporting Buy Rating - TipRanks
Ceribell, Inc.: Strong Financial Position and Strategic Management Justify Buy Rating Amid Tariff Challenges - TipRanks
CeriBell, Inc.Common Stock (NQ: CBLL - FinancialContent
With 49% stake, CeriBell, Inc. (NASDAQ:CBLL) seems to have captured institutional investors' interest - Yahoo Finance
CeriBell's IPO Lockup Ends April 9Here's Why We're Shorting It Today (NASDAQ:CBLL) - Seeking Alpha
CeriBell (NASDAQ:CBLL) Receives $32.60 Average PT from Brokerages - Defense World
CeriBell (NASDAQ:CBLL) Coverage Initiated by Analysts at LADENBURG THALM/SH SH - Defense World
Ladenburg Thalmann Initiates Coverage of CeriBell (CBLL) with Buy Recommendation - Nasdaq
This Lattice Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Ladenburg Thalmann Initiates CeriBell at Buy With $32 Price Target - MarketScreener
Critical Analysis: CeriBell (NASDAQ:CBLL) versus NeurAxis (NASDAQ:NRXS) - Defense World
Reviewing IRIDEX (NASDAQ:IRIX) & CeriBell (NASDAQ:CBLL) - Defense World
CeriBell’s (NASDAQ:CBLL) Lock-Up Period To Expire on April 9th - Defense World
Critical Comparison: CeriBell (NASDAQ:CBLL) and InMode (NASDAQ:INMD) - Defense World
Charles Schwab Investment Management Inc. Invests $2.50 Million in CeriBell (NASDAQ:CBLL) - Defense World
Bank of New York Mellon Corp Purchases New Holdings in CeriBell (NASDAQ:CBLL) - Defense World
PNC Financial Services Group Inc. Invests $47,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Announces Executive Compensation Adjustments - TipRanks
Ceribell executives receive pay increases and incentives By Investing.com - Investing.com Australia
Ceribell executives receive pay increases and incentives - Investing.com
Ceribell Inc (CBLL) 재무 분석
Ceribell Inc (CBLL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.01%
0.46%
자본화:
|
볼륨(24시간):